Merck narrows full-year sales guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. WMT
3. ROST
4. EL
5. SPY
6. BILL
7. ADI
8. MRK
9. MRNA
10. NTES

Go back to Merck narrows full-year sales guidance
Merck & Co. (NYSE: MRK) Delayed: 148.99 --0 (-0%)
Previous Close $148.99    52 Week High $65.46 
Open $148.99    52 Week Low $47.97 
Day High $148.99    P/E 101.35 
Day Low $148.99    EPS $1.47 
Volume 10,727